Is Allarity Therapeutics Inc (NASDAQ: ALLR) a Risk-Worthy Bet for Bold Investors?

In the last trading session, 1.11 million Allarity Therapeutics Inc (NASDAQ:ALLR) shares changed hands as the company’s beta touched -0.14. With the company’s per share price at $0.79 changed hands at -$0.03 or -3.70% during last session, the market valuation stood at $13.46M. ALLR’s last price was a discount, traded about -21925.32% off its 52-week high of $174.00. The share price had its 52-week low at $0.68, which suggests the last value was 13.92% up since then. When we look at Allarity Therapeutics Inc’s average trading volume, we note the 10-day average is 2.1 million shares, with the 3-month average coming to 2.78 million.

Analysts gave the Allarity Therapeutics Inc (ALLR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ALLR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Allarity Therapeutics Inc’s EPS for the current quarter is expected to be 0.

Allarity Therapeutics Inc (NASDAQ:ALLR) trade information

Instantly ALLR was in red as seen at the end of in last trading. With action -23.93%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -32.38%, with the 5-day performance at -23.93% in the red. However, in the 30-day time frame, Allarity Therapeutics Inc (NASDAQ:ALLR) is -23.93% down. Looking at the short shares, we see there were 0.48 million shares sold at short interest cover period of 0.2 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 84.72%.

ALLR Dividends

Allarity Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-13.

Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 16.80% of Allarity Therapeutics Inc shares while 2.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.83%.

Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 7.11 shares estimated at $5627.0 under it, the former controlled 0.16% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.07% of the shares, roughly 3.3 shares worth around $2607.0.